Hospira Healthcare Corporation v Kennedy Institute of Rheumatology
2016
A-327-16
Resolved
Biosimilars
Appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)
Counsel to:
Hospira Healthcare Corporation, Celltrion Healthcare Co. Ltd. and Celltrion Inc.
The decision is reported
here.
Meet the team
Warren Sprigings
Partner